Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06640491
PHASE1/PHASE2

Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)

Sponsor: The Methodist Hospital Research Institute

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to compare the efficacy of intravenous (IV) and intraosseous (IO) antibiotic administration techniques during primary total knee arthroplasty (TKA) in adults undergoing a TKA procedure at Houston Methodist Hospital. The main questions it aims to answer are: Does IO administration of vancomycin and cefazolin protect against perioperative exposure risks? Is there a difference in post-operative complication rates between IV and IO administration of these drugs? Participants will be randomized to receive either the standard of care IV administration of Vancomycin and Cefazolin, or the IO administration of Vancomycin and Cefazolin.

Official title: Intraosseous Vancomycin and Cefazolin vs Intravenous Administration in Primary Total Knee Arthroplasty

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-05-15

Completion Date

2035-12-01

Last Updated

2025-05-18

Healthy Volunteers

No

Interventions

DRUG

IO Administration of Cefazolin

Intraosseous injection of cefazolin to guard against infection.

DRUG

IO Administration of Vancomycin

Intraosseous injection of vancomycin to guard against infection.

DRUG

IV Administration of Cefazolin

Intravenous dose of cefazolin to guard against infection.

DRUG

IV Administration of Vancomycin

Intravenous dose of vancomycin to guard against infection.

Locations (1)

Houston Methodist Hospital

Houston, Texas, United States